Pharma Stock News

Acasti Pharma Inc. (ACST) Stock Price, News, Quote & History

Category: news

Acasti Pharma Inc. (ACST) Stock Price, News, Quote & History
Find the latest Acasti Pharma Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Albireo Pharma, Inc. (ALBO) Stock Price, News, Quote & History

Category: news

Albireo Pharma, Inc. (ALBO) Stock Price, News, Quote & History
Find the latest Albireo Pharma, Inc. (ALBO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Natco Pharma gets court nod for insecticide launch; stock surges …

Natco Pharma gets court nod for insecticide launch; stock surges …
Sep 20, 2022 · Natco Pharma shares have witnessed selling pressure in the recent past, with the stock hitting a 52-week low of ₹600.1 on September 12, 2022. The counter trades 30% lower than its 52-week high of ₹942.15 touched on January 17, 2022.

Stock market update: Nifty Pharma index falls 1.05%

Stock market update: Nifty Pharma index falls 1.05%
Aug 19, 2022 · On the other hand, Granules India(down 3.93 per cent), Glenmark Pharmaceuticals(down 3.33 per cent), Aurobindo Pharma(down 2.37 per cent), Strides Pharma Science(down 2.27 per cent) and Biocon(down 2.17 per cent) finished as the top losers of the day. The Nifty Pharma index closed 1.05 per cent down at 12799.95.

Stock market update: Nifty Pharma index advances 0.26%

Stock market update: Nifty Pharma index advances 0.26%
Sep 06, 2022 · Shutterstock.com India 10-year bond yield fell 0.34 per cent to 6.13 after trading in 6.13-6.16 range. NEW DELHI: The Nifty Pharma index closed on a positive note on Tuesday. Shares of Cipla(up 1.48 per cent), Glenmark Pharmaceuticals(up 1.21 per cent), Pfizer(up 0.8 per cent), Dr Reddys ...

Pharma Stock Roundup: FDA Authorization of Omicron Boosters, …

Pharma Stock Roundup: FDA Authorization of Omicron Boosters, …
Sep 01, 2022 · This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of ...

Novartis Stock: Undervalued Swiss Pharma Giant (NYSE:NVS)

Novartis Stock: Undervalued Swiss Pharma Giant (NYSE:NVS)
Aug 21, 2022 · Robert Way. Thesis. Novartis (NYSE:NVS) trades at a discount to fair value, in my opinion.Valued at a one-year forward P/E of < x14, the company is clearly trading cheap. Investors should consider ...

Popular Search

Recent Search